Didi Chen

Key Laboratory Of Diagnosis And Treatment Of Severe Hepato Pancreatic Diseases Of Zhejiang Province
Wenzhou, 325015, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Mutual communication between radiosensitive and radioresistant esophageal cancer cells modulates their radiosensitivity.

Mutual communication between radiosensitive and radioresistant esophageal cancer cells modulates their radiosensitivity.

Journal: Cell death & disease
Published: June 03, 2023

An analysis of the relationship of triglyceride glucose index with gastric cancer prognosis: A retrospective study.

An analysis of the relationship of triglyceride glucose index with gastric cancer prognosis: A retrospective study.

Journal: Cancer medicine
Published: April 12, 2023

Evaluation the benefits of additional radiotherapy for gastric cancer patients after D2 resection using CT based radiomics.

Evaluation the benefits of additional radiotherapy for gastric cancer patients after D2 resection using CT based radiomics.

Journal: La Radiologia medica
Published: January 23, 2023

Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways.

Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 07, 2021

Identification and Mechanism of the PD-1/PD-L1 Genomic Signature SORL1 as Protective Factor in Bladder Cancer.

Identification and Mechanism of the PD-1/PD-L1 Genomic Signature SORL1 as Protective Factor in Bladder Cancer.

Journal: Frontiers in genetics
Published: July 06, 2021

Immunological Classification of Pancreatic Carcinomas to Identify Immune Index and Provide a Strategy for Patient Stratification.

Immunological Classification of Pancreatic Carcinomas to Identify Immune Index and Provide a Strategy for Patient Stratification.

Journal: Frontiers in immunology
Published: June 01, 2021

Nivolumab for Metastatic Urothelial Cancer in a Renal Allograft Recipient With Subsequent Graft Rejection and Treatment Complete Remission: A Case Report.

Nivolumab for Metastatic Urothelial Cancer in a Renal Allograft Recipient With Subsequent Graft Rejection and Treatment Complete Remission: A Case Report.

Journal: Frontiers in oncology
Published: December 26, 2020

PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor-related cardiac dysfunction.

PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor-related cardiac dysfunction.

Journal: Journal for immunotherapy of cancer
Published: September 24, 2020

Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p.

Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p.

Journal: Journal of nanobiotechnology
Published: July 10, 2020

miR-20b and miR-125a promote tumorigenesis in radioresistant esophageal carcinoma cells.

miR-20b and miR-125a promote tumorigenesis in radioresistant esophageal carcinoma cells.

Journal: Aging
Published: February 13, 2020

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant.

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant.

Journal: Radiation oncology (London, England)
Published: October 07, 2019

Clinical Value Of Apatinib As A Salvage Treatment In Patients With Chemo-Refractory Advanced Cervical Cancer.

Clinical Value Of Apatinib As A Salvage Treatment In Patients With Chemo-Refractory Advanced Cervical Cancer.

Journal: OncoTargets and therapy
Published: September 09, 2019
Showing 1-12 of 18

Last Updated: 09/26/2026